Trial Profile
A Phase IV, Multi-centric clinical trial to systematically evaluate safety, reactogenicity and tolerability of Trivalent, Live Attenuated Seasonal Influenza vaccine of SIIL in large population
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 24 Oct 2017
Price :
$35
*
At a glance
- Drugs Influenza virus vaccine (Primary)
- Indications Influenza virus infections
- Focus Adverse reactions
- Sponsors Serum Institute of India
- 12 Oct 2017 Results assessing safety published in the Drug Safety.
- 02 Sep 2016 New trial record